Aspirin-Sensitive AsthmaRecent Advances in Management
作者:
Hae-Sim Park,
期刊:
BioDrugs
(ADIS Available online 2000)
卷期:
Volume 13,
issue 1
页码: 29-33
ISSN:1173-8804
年代: 2000
出版商: ADIS
关键词: Antiinflammatories, therapeutic use;Asthma, treatment;Corticosteroids, therapeutic use;Reviews on treatment
数据来源: ADIS
摘要:
Aspirin (ASA)-sensitive asthma is characterised by a typical sequence of symptoms, including intense eosinophilic inflammation of nasal and bronchial tissues. It is more commonly found in non-atopic, middle-aged female asthmatic patients with chronic rhino-sinusitis and/or nasal polyps. The lysine-aspirin bronchoprovocation test has become a widely used diagnostic test. When ASA-sensitive asthma is confirmed, complete avoidance of ASA/non-steroidal anti-inflammatory agents (NSAIDs) is crucial in preventing life-threatening adverse reactions. The basic principle of pharmacotherapy is step-wise treatment based upon anti-inflammatory therapy. Corticosteroids are the mainstay of therapy and anti-leukotriene agents may be indicated for treatment of the underlying disease. ASA desensitisation may reduce inflammatory mucosal disease symptoms, particularly in the nasal passage.
点击下载:
PDF
(59KB)
返 回